TE_93
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSx |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | ENSG00000235263 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 2.03 |
| Counts of samples | TCGA_tumor:100; TCGA_normal:7; GTEx:48 |
| TSS | chr1(-):9505023 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_93.1 | ENSG00000235263 | Chimeric | Non-coding | Non-coding | chr1(-):9501528,9501548,9503221,9503312,9504801,9505024 |
| teRNA_93.2 | ENSG00000235263 | Chimeric | Non-coding | Non-coding | chr1(-):9501528,9501548,9504801,9505024 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
